Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hongyan Tong

Showing results (41-50 of 209) with videos related to

Pageof 21
Sort By:
Ejhaem|January 26, 2026
Successful Treatment of Refractory Sweet's Syndrome With Adalimumab in a Myelodysplastic Syndrome PatientLiya Ma, Yaojia Shen, Jie Chang, et al.
Cell Transplantation|January 28, 2026
Incidence and clinical relevance of donor-derived recipient-specific anti-HLA antibodies in haploidentical hematopoietic stem cell transplantation: a retrospective studyXianbo Huang, Yanling Ren, Shasha Wang, et al.
Cancer|March 7, 2023
Chemotherapy with the use of next-generation tyrosine kinase inhibitors based on measurable residual disease has the potential to avoid hematopoietic stem cell transplantation in treatment for adults with Philadelphia chromosome-positive acute lymphoblastic leukemiaMixue Xie, Ting Shi, Qi Jiang, et al.
Journal of Translational Medicine|June 14, 2014
Sequential combination of decitabine and idarubicin synergistically enhances anti-leukemia effect followed by demethylating Wnt pathway inhibitor promoters and downregulating Wnt pathway nuclear targetKongfei Li, Chao Hu, Chen Mei, et al.
International Journal of Clinical and Experimental Pathology|January 18, 2020
Expression of hypoxia-inducible factor-1a predicts benefit from rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone in diffuse large B-cell lymphomaJie Jin, Lihong Cao, Lijun Wang, et al.
International Journal of Cancer|June 25, 2025
Prognostic impact of extramedullary disease in acute myeloid leukemia: A meta-analysisYufan Lin, Ping Liu, Qiqi Zhuang, et al.
Leukemia Research|November 12, 2024
Thiotepa-busulfan-fludarabine conditioning as a promising approach prior to haploidentical allogeneic hematopoietic stem cell transplantation in hematological malignancies with extramedullary involvement: Insights from a single centerXianbo Huang, Xianhui Wu, Shasha Wang, et al.
Blood Cancer Journal|May 29, 2026
Impact of the clonal architecture and probable biallelic inactivation of TET2 mutations in myelodysplastic neoplasmsYudi Zhang, Wei Wang, Qiaoli Li, et al.
BMC Cancer|August 5, 2024
Clinical features and prognosis of patients with myeloid neoplasms harboring t(7;11)(p15;p15) translocation: a single-center retrospective studyLin Liu, Shuqi Zhao, Lu Wang, et al.
Frontiers of Medicine|April 4, 2017
Salvage therapy with lenalidomide containing regimen for relapsed/refractory Castleman disease: a report of three casesXinping Zhou, Juying Wei, Yinjun Lou, et al.
Pageof 21

Showing results (41-50 of 209) with videos related to

Sort By:
Pageof 21
Ejhaem|January 26, 2026
Successful Treatment of Refractory Sweet's Syndrome With Adalimumab in a Myelodysplastic Syndrome PatientLiya Ma, Yaojia Shen, Jie Chang, et al.
Cell Transplantation|January 28, 2026
Incidence and clinical relevance of donor-derived recipient-specific anti-HLA antibodies in haploidentical hematopoietic stem cell transplantation: a retrospective studyXianbo Huang, Yanling Ren, Shasha Wang, et al.
Cancer|March 7, 2023
Chemotherapy with the use of next-generation tyrosine kinase inhibitors based on measurable residual disease has the potential to avoid hematopoietic stem cell transplantation in treatment for adults with Philadelphia chromosome-positive acute lymphoblastic leukemiaMixue Xie, Ting Shi, Qi Jiang, et al.
Journal of Translational Medicine|June 14, 2014
Sequential combination of decitabine and idarubicin synergistically enhances anti-leukemia effect followed by demethylating Wnt pathway inhibitor promoters and downregulating Wnt pathway nuclear targetKongfei Li, Chao Hu, Chen Mei, et al.
International Journal of Clinical and Experimental Pathology|January 18, 2020
Expression of hypoxia-inducible factor-1a predicts benefit from rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone in diffuse large B-cell lymphomaJie Jin, Lihong Cao, Lijun Wang, et al.
International Journal of Cancer|June 25, 2025
Prognostic impact of extramedullary disease in acute myeloid leukemia: A meta-analysisYufan Lin, Ping Liu, Qiqi Zhuang, et al.
Leukemia Research|November 12, 2024
Thiotepa-busulfan-fludarabine conditioning as a promising approach prior to haploidentical allogeneic hematopoietic stem cell transplantation in hematological malignancies with extramedullary involvement: Insights from a single centerXianbo Huang, Xianhui Wu, Shasha Wang, et al.
Blood Cancer Journal|May 29, 2026
Impact of the clonal architecture and probable biallelic inactivation of TET2 mutations in myelodysplastic neoplasmsYudi Zhang, Wei Wang, Qiaoli Li, et al.
BMC Cancer|August 5, 2024
Clinical features and prognosis of patients with myeloid neoplasms harboring t(7;11)(p15;p15) translocation: a single-center retrospective studyLin Liu, Shuqi Zhao, Lu Wang, et al.
Frontiers of Medicine|April 4, 2017
Salvage therapy with lenalidomide containing regimen for relapsed/refractory Castleman disease: a report of three casesXinping Zhou, Juying Wei, Yinjun Lou, et al.
Pageof 21